Cargando…

Spinal cord injury: potential neuroprotective therapy based on neural-derived peptides

Detalles Bibliográficos
Autores principales:	García, Elisa, Mondragón-Caso, José, Ibarra, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204227/ https://www.ncbi.nlm.nih.gov/pubmed/28123415 http://dx.doi.org/10.4103/1673-5374.194718

Ejemplares similares

Immunomodulation as a neuroprotective strategy after spinal cord injury
por: Monteiro, Susana, et al.
Publicado: (2018)

Neuroprotective effect of immunomodulatory peptides in rats with traumatic spinal cord injury
por: Parra-Villamar, Dulce, et al.
Publicado: (2020)

Development of Protective Autoimmunity by Immunization with a Neural-Derived Peptide Is Ineffective in Severe Spinal Cord Injury
por: Martiñón, Susana, et al.
Publicado: (2012)

Immunization with neural‐derived peptides increases neurogenesis in rats with chronic spinal cord injury
por: Rodríguez‐Barrera, Roxana, et al.
Publicado: (2020)

Modification of autophagy-lysosomal pathway as a neuroprotective treatment for spinal cord injury
por: Lipinski, Marta M., et al.
Publicado: (2015)

Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injury
por: Rabchevsky, Alexander G., et al.
Publicado: (2017)

Reorganization of spinal neural circuitry and functional recovery after spinal cord injury
por: Nardone, Raffaele, et al.
Publicado: (2015)

Extracellular vesicles for neural regeneration after spinal cord injury
por: Lim, Young-Ju, et al.
Publicado: (2023)

Immunization with a Neural-Derived Peptide Protects the Spinal Cord from Apoptosis after Traumatic Injury
por: Rodríguez-Barrera, Roxana, et al.
Publicado: (2013)

Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions
por: Kopper, Timothy J., et al.
Publicado: (2020)

Neural prostheses for restoring functions lost after spinal cord injury
por: Fakhoury, Marc
Publicado: (2015)

Transcription factors promote neural regeneration after spinal cord injury
por: Finkel, Zachary, et al.
Publicado: (2022)

Combinatorial therapies for spinal cord injury: strategies to induce regeneration
por: Gomes, Eduardo D., et al.
Publicado: (2019)

Repositioning imatinib for spinal cord injury
por: Kjell, Jacob, et al.
Publicado: (2015)

Bridging the injured spinal cord with neural stem cells
por: Dulin, Jennifer N., et al.
Publicado: (2014)

Neuromodulator interactions and spinal cord injury in lamprey
por: Parker, David, et al.
Publicado: (2018)

Endogenous neural progenitor cells in the repair of the injured spinal cord
por: Mao, Yilin, et al.
Publicado: (2016)

Spinal cord injury: can we repair spinal cord non-invasively by using magnetic stimulation?
por: Delarue, Quentin, et al.
Publicado: (2021)

Glial cell line-derived neurotrophic factor as a treatment after spinal cord injury
por: Ortmann, Stephen D., et al.
Publicado: (2018)

Immunization with neural derived peptides plus scar removal induces a permissive microenvironment, and improves locomotor recovery after chronic spinal cord injury
por: Rodríguez-Barrera, Roxana, et al.
Publicado: (2017)

Current stem cell treatments for spinal cord injury
por: Vawda, R, et al.
Publicado: (2012)

Technical comments on rodent spinal cord injuries models
por: Zhang, Zoe, et al.
Publicado: (2014)

Micromechanical adaptation as a treatment for spinal cord injury
por: Estrada, Veronica, et al.
Publicado: (2019)

Rethinking the Body in the Brain after Spinal Cord Injury
por: Leemhuis, Erik, et al.
Publicado: (2022)

In vivo astrocyte reprogramming following spinal cord injury
por: Gerber, Yannick N., et al.
Publicado: (2023)

Neural regeneration after spinal cord injury treatment by lavandula angustifolia and human umbilical mesanchymal stem cell transplantation
por: Yaghoobi, Kayvan
Publicado: (2017)

Effect of microenvironment modulation on stem cell therapy for spinal cord injury pain
por: Liu, Sufang, et al.
Publicado: (2014)

Anterior chamber associated immune deviation used as a neuroprotective strategy in rats with spinal cord injury
por: Pineda-Rodriguez, Beatriz, et al.
Publicado: (2017)

Prazosin: a potential new management tool for iatrogenic autonomic dysreflexia in individuals with spinal cord injury?
por: Zheng, Mei M.Z., et al.
Publicado: (2015)

Potential therapeutic mechanism of traditional Chinese medicine monomers on neurological recovery after spinal cord injury
por: Zhang, Tao, et al.
Publicado: (2021)

Enhanced motor cortex excitability after spinal cord injury
por: Raffaele, Nardone
Publicado: (2015)

Therapeutic implications of advanced age at time of spinal cord injury
por: Stewart, Andrew N., et al.
Publicado: (2019)

Disconnected Body Representation: Neuroplasticity Following Spinal Cord Injury
por: Leemhuis, Erik, et al.
Publicado: (2019)

Transneuronal delivery of designer cytokines: perspectives for spinal cord injury
por: Terheyden-Keighley, Daniel, et al.
Publicado: (2021)

Immunization with Cop-1 promotes neuroprotection and neurogenesis after ischemic stroke
por: Cruz, Yolanda, et al.
Publicado: (2015)

New insight into curcumin-based therapy in spinal cord injuries: CISD2 regulation
por: Lin, Chai-Ching, et al.
Publicado: (2016)

Interactions of primary insult biomechanics and secondary cascades in spinal cord injury: implications for therapy
por: Orr, Michael B., et al.
Publicado: (2017)

Spinal Cord-derived Neural Precursor Cells as a Preventive Therapy for Spinal Cord Injury
por: Hosseini, Seyed Mojtaba, et al.
Publicado: (2018)

Neuroprotection by diarylpropionitrile in mice with spinal cord injury
por: Suwanna, Nirut, et al.
Publicado: (2014)

Neuroprotective role of Noggin in spinal cord injury
por: Al-Sammarraie, Nadia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5laedclhpgh689tol377jnl2b9